Entourage Health Corp.

Equities

ENTG

CA2938611001

Pharmaceuticals

Delayed Toronto S.E. 09:30:00 2024-03-28 am EDT 5-day change 1st Jan Change
0.01 CAD 0.00% Intraday chart for Entourage Health Corp. 0.00% -33.33%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Entourage Health Corp. Announces Resignation of Lu Cacioppo from its Board of Directors CI
Entourage Health Provides Corporate Update MT
Entourage Health Corp. Announces Vincent Doré, Entourage's Chief Legal Officer and Corporate Secretary, Will Step Down, Effective December 18, 2023 CI
Transcript : Entourage Health Corp., Q3 2023 Earnings Call, Nov 28, 2023
Entourage Health Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Entourage Health Signs Amended Supply Agreement With HEXO MT
Entourage Health Brief: Announcing Amendment to Key Supply Agreement MT
Entourage Health Announces Amendment to Key Supply Agreement CI
Entourage Health Posts Q2 Results; Shares Up MT
Transcript : Entourage Health Corp., Q2 2023 Earnings Call, Aug 30, 2023
Entourage Health Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Entourage Health Announces New Product Offerings MT
Entourage Health Corp. Launches Dime Bag Branded Pre-Rolls and Introduces Syndicate: A Collective of Craft Cannabis CI
Entourage Health Announces International Sale of Bulk Cannabis to Australia MT
Entourage Health Corp. Announces International Sale of Bulk Cannabis to Australia CI
An unknown buyer acquired Strathroy facility of Entourage Health Corp. CI
Entourage Health Restructures Senior Secured Debt MT
Entourage Health Corp. Announces Restructuring of Senior Secured Debt CI
Transcript : Entourage Health Corp. - Shareholder/Analyst Call
Transcript : Entourage Health Corp., Q1 2023 Earnings Call, May 30, 2023
Entourage Health Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Entourage Health Corp. Auditor Raises 'Going Concern' Doubt CI
Entourage Health Corp. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Entourage Health Corp. Continues to Expand Medical Offerings with Launch of CBD Chewing Gum and SignsNew Union Group to the Starseed Medicinal Program CI
Irwin Naturals Launches New Product in Canada MT
Chart Entourage Health Corp.
More charts
Entourage Health Corp. is a Canada-based license holder producing and distributing cannabis products for both the medical and adult-use markets. The Company owns and operates a 26,000 square feet indoor facility in Aylmer, Ontario (the Aylmer Facility), specializing in product development and fulfillment for both adult-use and medical cannabis. The Company is focused on building a portfolio of brands in the Canadian market, including its premium brand Color Cannabis, mainstream brand Saturday Cannabis, medical cannabis product brand Starseed Medicinal and its craft cannabis brand Syndicate Cannabis. The Company produces a diverse portfolio of cannabis and cannabis derivative products, including oils, capsules, soft chews, topicals, beverages and vapes, for sale in both the medical and adult-use markets across Canada. Its elite adult-use product portfolio includes Color Cannabis, Saturday Cannabis and now Dime Bag and Syndicate, sold across eight provincial distribution agencies.
More about the company

Annual profits - Rate of surprise

  1. Stock
  2. Equities
  3. Stock Entourage Health Corp. - Toronto S.E.
  4. News Entourage Health Corp.
  5. WeedMD : Delays Filing of 2020 Annual Financial Disclosure Due to CFO Resignation